PriceTargets.com logo

FIGS - FIGS Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $5.35
  • Forecasted Upside: 14.32%
  • Number of Analysts: 5
  • Breakdown:
  • 2 Sell Ratings
  • 2 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$4.68 As of 03/25/2025 04:58 PM ET
▼ -0.16 (-3.31%)

This chart shows the closing price for FIGS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New FIGS Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for FIGS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for FIGS

Analyst Price Target is $5.35
▲ +14.32% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for FIGS in the last 3 months. The average price target is $5.35, with a high forecast of $7.00 and a low forecast of $4.00. The average price target represents a 14.32% upside from the last price of $4.68.

This chart shows the closing price for FIGS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 5 contributing investment analysts is to reduce stock in FIGS. This rating has held steady since March 2024, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
10/2/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
12/31/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
3/30/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 2 sell ratings
Ratings as of
6/28/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
9/26/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
12/25/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
2/23/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
3/25/2025

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/28/2025Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$7.00 ➝ $7.00
2/20/2025Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$7.00 ➝ $7.00
12/10/2024The Goldman Sachs GroupLower TargetSell ➝ Sell$5.00 ➝ $4.50
11/13/2024Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$7.00 ➝ $7.00
11/12/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$5.00 ➝ $4.00
11/4/2024Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$7.00 ➝ $7.00
8/9/2024The Goldman Sachs GroupBoost TargetSell ➝ Sell$4.25 ➝ $4.75
8/5/2024Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$6.00 ➝ $6.00
6/13/2024Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$6.00 ➝ $6.00
5/10/2024Roth MkmLower TargetBuy ➝ Buy$7.50 ➝ $6.75
5/10/2024Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$6.00 ➝ $6.00
5/3/2024Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$6.00 ➝ $6.00
4/23/2024The Goldman Sachs GroupLower TargetSell ➝ Sell$4.85 ➝ $4.25
4/2/2024Bank of AmericaReiterated RatingNeutral ➝ Underperform$8.50 ➝ $4.50
3/8/2024OppenheimerDowngradeOutperform ➝ Market Perform
3/1/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$7.00 ➝ $5.00
2/29/2024The Goldman Sachs GroupLower TargetSell ➝ Sell$6.75 ➝ $4.85
2/29/2024Telsey Advisory GroupDowngradeOutperform ➝ Market Perform$11.00 ➝ $6.00
2/22/2024Telsey Advisory GroupReiterated RatingOutperform ➝ Outperform$11.00
1/24/2024BarclaysUpgradeUnderweight ➝ Equal Weight$7.00
10/26/2023Telsey Advisory GroupReiterated RatingOutperform ➝ Outperform$11.00
9/15/2023Telsey Advisory GroupReiterated RatingOutperform ➝ Outperform$11.00
8/7/2023BarclaysBoost TargetUnderweight ➝ Underweight$5.00 ➝ $7.00
8/4/2023Telsey Advisory GroupReiterated RatingOutperform ➝ Outperform$11.00
7/28/2023Telsey Advisory GroupReiterated RatingOutperform ➝ Outperform$11.00
7/21/2023Telsey Advisory GroupReiterated RatingOutperform ➝ Outperform$11.00
7/17/2023Raymond JamesDowngradeOutperform ➝ Market Perform
5/3/2023Roth MkmInitiated CoverageBuy$9.00
5/2/2023BarclaysDowngradeEqual Weight ➝ Underweight
3/21/2023OppenheimerLower TargetOutperform$12.00 ➝ $9.00
3/1/2023Telsey Advisory GroupLower TargetOutperform$12.00 ➝ $11.00
3/1/2023The Goldman Sachs GroupBoost TargetSell$5.50 ➝ $6.25
3/1/2023Credit Suisse GroupLower TargetOutperform$12.00 ➝ $10.00
2/22/2023Telsey Advisory GroupBoost TargetOutperform$9.00 ➝ $12.00
2/1/2023Raymond JamesBoost TargetOutperform$8.00 ➝ $10.00
1/31/2023CowenBoost TargetMarket Perform$6.00 ➝ $11.00
11/17/2022OppenheimerLower TargetOutperform$22.00 ➝ $12.00
11/16/2022Piper SandlerLower Target$10.00
11/16/2022GuggenheimLower Target$12.00
11/16/2022Credit Suisse GroupLower Target$12.00
11/16/2022CowenLower Target$6.00
11/14/2022The Goldman Sachs GroupLower TargetSell$7.50 ➝ $5.50
11/14/2022BarclaysLower TargetEqual Weight$9.00 ➝ $6.00
11/11/2022Morgan StanleyLower TargetEqual Weight$10.00 ➝ $7.00
11/11/2022Raymond JamesReiterated RatingStrong-Buy ➝ Outperform$12.00 ➝ $8.00
11/11/2022Telsey Advisory GroupLower TargetOutperform$10.00 ➝ $9.00
11/8/2022Raymond JamesLower TargetStrong-Buy$15.00 ➝ $12.00
11/4/2022Telsey Advisory GroupLower TargetOutperform$17.00 ➝ $10.00
10/27/2022CowenLower Target$9.00
10/25/2022Morgan StanleyLower TargetEqual Weight$11.00 ➝ $10.00
10/14/2022BarclaysDowngradeOverweight ➝ Equal Weight$15.00 ➝ $9.00
8/8/2022Morgan StanleyLower TargetEqual Weight$12.00 ➝ $11.00
8/5/2022BarclaysBoost TargetOverweight ➝ Overweight$13.00 ➝ $15.00
7/22/2022Piper SandlerInitiated CoverageOverweight ➝ Overweight$22.00 ➝ $15.00
7/21/2022KeyCorpInitiated CoverageSector Weight
7/21/2022The Goldman Sachs GroupDowngradeNeutral ➝ Sell$14.00 ➝ $7.00
6/30/2022Raymond JamesInitiated CoverageStrong-Buy$15.00
5/16/2022BarclaysLower TargetOverweight ➝ NA$34.00 ➝ $13.00
5/16/2022OppenheimerLower TargetNA$45.00 ➝ $22.00
5/16/2022Bank of AmericaDowngradeBuy ➝ Neutral$32.00 ➝ $12.00
5/16/2022FIG PartnersDowngradeBuy ➝ Neutral$32.00 ➝ $12.00
5/13/2022Credit Suisse GroupLower TargetOutperform ➝ Outperform$26.00 ➝ $15.00
4/7/2022Truist FinancialInitiated CoverageBuy$32.00
3/10/2022BarclaysLower TargetOverweight$38.00 ➝ $34.00
3/9/2022CowenBoost TargetOutperform ➝ Outperform$23.00 ➝ $24.00
3/9/2022Bank of AmericaLower TargetBuy$40.00 ➝ $32.00
3/9/2022Credit Suisse GroupLower TargetOutperform$34.00 ➝ $26.00
3/9/2022Piper SandlerLower TargetOverweight ➝ Overweight$45.00 ➝ $36.00
3/3/2022Telsey Advisory GroupLower TargetOutperform$46.00 ➝ $30.00
3/1/2022The Goldman Sachs GroupLower TargetNeutral$35.00 ➝ $30.00
2/7/2022CowenDowngradeOutperform ➝ Market Perform$23.00
1/20/2022KeyCorpLower TargetOverweight$45.00 ➝ $34.00
1/11/2022Credit Suisse GroupLower TargetOutperform$42.00 ➝ $34.00
11/11/2021Credit Suisse GroupBoost TargetOutperform$41.00 ➝ $42.00
8/30/2021Piper SandlerReiterated RatingBuy$45.00
8/13/2021Morgan StanleyBoost TargetEqual Weight$34.00 ➝ $36.00
8/13/2021Telsey Advisory GroupBoost TargetOutperform$43.00 ➝ $46.00
6/21/2021GuggenheimInitiated CoverageBuy$45.00
6/21/2021The Goldman Sachs GroupInitiated CoverageNeutral$28.00
6/21/2021Telsey Advisory GroupInitiated CoverageOutperform$43.00
6/21/2021OppenheimerInitiated CoverageOutperform$45.00
6/21/2021BarclaysInitiated CoverageOverweight$50.00
6/21/2021KeyCorpInitiated CoverageOverweight$45.00
6/21/2021Morgan StanleyInitiated CoverageEqual Weight$34.00
6/21/2021Bank of AmericaInitiated CoverageBuy$42.00
6/21/2021Piper SandlerInitiated CoverageOverweight$44.00
6/21/2021CowenInitiated CoverageOutperform$43.00
6/21/2021FIG PartnersInitiated CoverageBuy$42.00
(Data available from 3/25/2020 forward)

News Sentiment Rating

0.57 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/27/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/26/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/26/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/25/2024
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/24/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/23/2025
  • 3 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
3/25/2025

Current Sentiment

  • 3 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

FIGS logo
FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. It also offers sports bras, performance leggings, tops, super-soft pima cotton tops, vests, fleeces, and jackets; necessities, scrub caps, lanyards, badge reels, tote bags, baseball caps, and beanies. The company markets and sells its products to healthcare professionals through its direct-to-consumer digital platform comprising website, mobile app, and B2B business, as well as retail store. FIGS, Inc. was founded in 2013 and is headquartered in Santa Monica, California. FIGS, Inc.
Read More

Today's Range

Now: $4.68
Low: $4.63
High: $4.76

50 Day Range

MA: $5.27
Low: $4.35
High: $6.20

52 Week Range

Now: $4.68
Low: $4.18
High: $7.06

Volume

2,191,553 shs

Average Volume

2,950,279 shs

Market Capitalization

$760.59 million

P/E Ratio

78.00

Dividend Yield

N/A

Beta

1.26

Frequently Asked Questions

What sell-side analysts currently cover shares of FIGS?

The following sell-side analysts have issued reports on FIGS in the last year: Bank of America Co., Barclays PLC, Roth Mkm, Telsey Advisory Group, and The Goldman Sachs Group, Inc..
View the latest analyst ratings for FIGS.

What is the current price target for FIGS?

0 Wall Street analysts have set twelve-month price targets for FIGS in the last year. Their average twelve-month price target is $5.35, suggesting a possible upside of 14.7%. Telsey Advisory Group has the highest price target set, predicting FIGS will reach $7.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $4.00 for FIGS in the next year.
View the latest price targets for FIGS.

What is the current consensus analyst rating for FIGS?

FIGS currently has 2 sell ratings, 2 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for FIGS.

What other companies compete with FIGS?

Other companies that are similar to FIGS include Ermenegildo Zegna, Under Armour, Under Armour, Capri and Canada Goose. Learn More about companies similar to FIGS.

How do I contact FIGS's investor relations team?

FIGS's physical mailing address is 2834 COLORADO AVENUE SUITE 100, SANTA MONICA CA, 90404. The company's listed phone number is 424-300-8330 and its investor relations email address is [email protected]. The official website for FIGS is www.wearfigs.com. Learn More about contacing FIGS investor relations.